Quintiles IMS Holdings Inc (Q) - Financial and Strategic SWOT Analysis Review

August 2017 | 47 pages | ID: QA52B5FCF62EN
GlobalData

Abstracts

Quintiles IMS Holdings Inc (Q) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Quintiles IMS Holdings Inc (Quintiles IMS) is a provider of integrated information and technology facilitated healthcare services. The company is formed through a merger between Quintiles and IMS Health. It provides various services including clinical development solutions, clinical trial solutions, commercial solutions, database and real world insights to the clients. Quintiles IMS also provides technology solutions including cloud base solutions to support the customer relationship management. It serves customer health companies, pharmaceutical companies, device and diagnostic companies and biotechnology companies. The company has offices in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Quintiles IMS is headquartered in Durham, North Carolina, the US. It serves customer health companies, pharmaceutical companies, device and diagnostic companies and biotechnology companies. The company has offices in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Quintiles IMS is headquartered in Durham, North Carolina, the US.

Quintiles IMS Holdings Inc Key Recent Developments

Aug 03,2017: QuintilesIMS reports second-quarter 2017 results
Jul 26,2017: Colleen Goggins joins QuintilesIMS board of directors
Nov 30,2016: Quintiles IMS Holdings appoints president of R&D solutions business unit
Jul 27,2016: Quintiles 2nd Quarter 2016 Results
Jun 21,2016: Quintiles Unveils Solution Design Studio

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Quintiles IMS Holdings Inc - Key Facts
Quintiles IMS Holdings Inc - Key Employees
Quintiles IMS Holdings Inc - Key Employee Biographies
Quintiles IMS Holdings Inc - Major Products and Services
Quintiles IMS Holdings Inc - Company Statement
Quintiles IMS Holdings Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Quintiles IMS Holdings Inc - Business Description
Quintiles IMS Holdings Inc - Corporate Strategy
Quintiles IMS Holdings Inc - SWOT Analysis
SWOT Analysis - Overview
Quintiles IMS Holdings Inc - Strengths
Quintiles IMS Holdings Inc - Weaknesses
Quintiles IMS Holdings Inc - Opportunities
Quintiles IMS Holdings Inc - Threats
Quintiles IMS Holdings Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Quintiles IMS Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Quintiles IMS Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Quintiles IMS Holdings Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Nov 30, 2016: Quintiles IMS Holdings appoints president of R&D solutions business unit
Jul 27, 2016: Quintiles 2nd Quarter 2016 Results
May 03, 2016: Quintiles 1st Quarter 2016 Results
Feb 11, 2016: Quintiles 4th Quarter and Full Year 2015 Results and 2016 Guidance

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Quintiles IMS Holdings Inc, Key Facts
Quintiles IMS Holdings Inc, Key Employees
Quintiles IMS Holdings Inc, Key Employee Biographies
Quintiles IMS Holdings Inc, Major Products and Services
Quintiles IMS Holdings Inc, Subsidiaries
Quintiles IMS Holdings Inc, Joint Venture
Quintiles IMS Holdings Inc, Key Competitors
Quintiles IMS Holdings Inc, Ratios based on current share price
Quintiles IMS Holdings Inc, Annual Ratios
Quintiles IMS Holdings Inc, Annual Ratios (Cont.1)
Quintiles IMS Holdings Inc, Annual Ratios (Cont.2)
Quintiles IMS Holdings Inc, Interim Ratios
Quintiles IMS Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Quintiles IMS Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Quintiles IMS Holdings Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Quintiles IMS Holdings Inc, Performance Chart (2012 - 2016)
Quintiles IMS Holdings Inc, Ratio Charts
Quintiles IMS Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Quintiles IMS Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Veeva Systems Inc.
PRA Health Sciences Inc
Parexel International Corp
INC Research Holdings Inc
AcelRx Pharmaceuticals Inc